Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1995 Apr;72(4):325–329. doi: 10.1136/adc.72.4.325

Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.

H Rubie 1, M Juricic 1, S Claeyssens 1, A Krimou 1, J Lemozy 1, P Izard 1, J Guitard 1, M Ane 1, M F Prere 1, F Fedacou 1, et al.
PMCID: PMC1511239  PMID: 7763065

Abstract

An evaluation of totally implanted venous access systems inserted in 163 consecutive children with cancer is reported. From 1988 to 1994, 180 subcutaneous ports were inserted in children more than 1 year old. Initial diagnosis was acute leukaemia (n = 79), non-Hodgkin's lymphoma (n = 33), and solid tumour (n = 51). Median age was 85 months. All venous procedures were performed through the device. Chemotherapy was either moderate (n = 13) or intensive (n = 119) or very intensive (n = 48), including 16 patients undergoing marrow transplantation. Cumulative venous access totalled 55,770 patient days with a mean of 305 days/subcutaneous port. The cause of device removal was, end of treatment (n = 111), death due to malignancy (n = 20), catheter related infection (n = 7), and occlusion of the system (n = 4). Mechanical complications occurred in 19 ports; 16 were due to clots, of which 14 were cleared with instillation of urokinase. Documented infectious episodes occurred in 47 ports, recurred once in 14, and twice in five cases. Among these infections, 47 were septicaemic; 31 due to Staphylococcus epidermidis. Twenty seven of initial septic episodes were considered to be catheter related; the rate was 15%/subcutaneous port or 0.05/100 catheter days. Risk factors for the development of a first infection were age below 4 years and the time of use. Since February 1993, vancomycin (50 micrograms/ml) has been given and this has reduced the rate of S epidermidis infection from 26/83 subcutaneous port to 4/97. Life table analysis showed that the infection free interval for staphylococcus was significantly better after this technique ws initiated (log rank rest=0.02). Time saved was approximately 30minutes/patient/week compared with external catheters, or 45 hours/month for the cohort of children treated. Subcutaneous ports in paediatric cancer patients are reliable, safe, and durable and may offer an attractive alternative to external catheters for prolonged venous access and intensive treatment.

Full text

PDF
325

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becton D. L., Kletzel M., Golladay E. S., Hathaway G., Berry D. H. An experience with an implanted port system in 66 children with cancer. Cancer. 1988 Jan 15;61(2):376–378. doi: 10.1002/1097-0142(19880115)61:2<376::aid-cncr2820610229>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]
  2. Cairo M. S., Spooner S., Sowden L., Bennetts G. A., Towne B., Hodder F. Long-term use of indwelling multipurpose silastic catheters in pediatric cancer patients treated with aggressive chemotherapy. J Clin Oncol. 1986 May;4(5):784–788. doi: 10.1200/JCO.1986.4.5.784. [DOI] [PubMed] [Google Scholar]
  3. Conly J. M., Grieves K., Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis. 1989 Feb;159(2):310–319. doi: 10.1093/infdis/159.2.310. [DOI] [PubMed] [Google Scholar]
  4. Darbyshire P. J., Weightman N. C., Speller D. C. Problems associated with indwelling central venous catheters. Arch Dis Child. 1985 Feb;60(2):129–134. doi: 10.1136/adc.60.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Decker M. D., Edwards K. M. Central venous catheter infections. Pediatr Clin North Am. 1988 Jun;35(3):579–612. doi: 10.1016/s0031-3955(16)36473-2. [DOI] [PubMed] [Google Scholar]
  6. Gyves J. W., Ensminger W. D., Niederhuber J. E., Dent T., Walker S., Gilbertson S., Cozzi E., Saran P. A totally implanted injection port system for blood sampling and chemotherapy administration. JAMA. 1984 May 18;251(19):2538–2541. [PubMed] [Google Scholar]
  7. Halperin D. L., Koren G., Attias D., Pellegrini E., Greenberg M. L., Wyss M. Topical skin anesthesia for venous, subcutaneous drug reservoir and lumbar punctures in children. Pediatrics. 1989 Aug;84(2):281–284. [PubMed] [Google Scholar]
  8. Hanks G. W., White I. Local anaesthetic creams. BMJ. 1988 Nov 12;297(6658):1215–1216. doi: 10.1136/bmj.297.6658.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ingram J., Weitzman S., Greenberg M. L., Parkin P., Filler R. Complications of indwelling venous access lines in the pediatric hematology patient: a prospective comparison of external venous catheters and subcutaneous ports. Am J Pediatr Hematol Oncol. 1991 Summer;13(2):130–136. doi: 10.1097/00043426-199122000-00003. [DOI] [PubMed] [Google Scholar]
  10. Lokich J. J., Bothe A., Jr, Benotti P., Moore C. Complications and management of implanted venous access catheters. J Clin Oncol. 1985 May;3(5):710–717. doi: 10.1200/JCO.1985.3.5.710. [DOI] [PubMed] [Google Scholar]
  11. McGovern B., Solenberger R., Reed K. A totally implantable venous access system for long-term chemotherapy in children. J Pediatr Surg. 1985 Dec;20(6):725–727. doi: 10.1016/s0022-3468(85)80033-6. [DOI] [PubMed] [Google Scholar]
  12. Messing B., Peitra-Cohen S., Debure A., Beliah M., Bernier J. J. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988 Mar-Apr;12(2):185–189. doi: 10.1177/0148607188012002185. [DOI] [PubMed] [Google Scholar]
  13. Mirro J., Jr, Rao B. N., Stokes D. C., Austin B. A., Kumar M., Dahl G. V., Colten M., Balas L., Rafferty M., Hancock M. A prospective study of Hickman/Broviac catheters and implantable ports in pediatric oncology patients. J Clin Oncol. 1989 Feb;7(2):214–222. doi: 10.1200/JCO.1989.7.2.214. [DOI] [PubMed] [Google Scholar]
  14. Pegelow C. H., Narvaez M., Toledano S. R., Davis J., Oiticica C., Buckner D. Experience with a totally implantable venous device in children. Am J Dis Child. 1986 Jan;140(1):69–71. doi: 10.1001/archpedi.1986.02140150071040. [DOI] [PubMed] [Google Scholar]
  15. Schwartz C., Henrickson K. J., Roghmann K., Powell K. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms. J Clin Oncol. 1990 Sep;8(9):1591–1597. doi: 10.1200/JCO.1990.8.9.1591. [DOI] [PubMed] [Google Scholar]
  16. Shulman R. J., Rahman S., Mahoney D., Pokorny W. J., Bloss R. A totally implanted venous access system used in pediatric patients with cancer. J Clin Oncol. 1987 Jan;5(1):137–140. doi: 10.1200/JCO.1987.5.1.137. [DOI] [PubMed] [Google Scholar]
  17. Sitges-Serra A., Linares J., Garau J. Catheter sepsis: the clue is the hub. Surgery. 1985 Mar;97(3):355–357. [PubMed] [Google Scholar]
  18. van Hoff J., Berg A. T., Seashore J. H. The effect of right atrial catheters on infectious complications of chemotherapy in children. J Clin Oncol. 1990 Jul;8(7):1255–1262. doi: 10.1200/JCO.1990.8.7.1255. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES